Trulieve Cannabis Corp. 8-K

What Happened Trulieve Cannabis Corp. announced on June 9, 2026 that its Board authorized a share repurchase program allowing the company to buy back up to the lesser of $50 million in aggregate value or 8,495,038 subordinate voting shares (about 5% of outstanding shares as of June 8, 2026). The program covers a 12‑month period and will expire on June 16, 2027. Any shares repurchased under the program will be cancelled.

Key Details

• Authorization date: June 9, 2026; program expiration: June 16, 2027.
• Maximum repurchase: the lesser of $50,000,000 or 8,495,038 subordinate voting shares (≈5% of shares outstanding as of June 8, 2026).
• Repurchases will be executed in accordance with applicable securities laws and may be suspended, modified, or discontinued at the company’s discretion.
• Repurchase program does not obligate the company to buy any specific number of shares; repurchased shares will be cancelled.

Why It Matters A board‑authorized buyback can affect per‑share metrics (like earnings per share) by reducing share count if repurchases occur and shares are cancelled. For investors, the program signals the company has authorized use of capital for potential share repurchases, but it is discretionary and not a commitment to spend the full amount. The timing, size and actual impact will depend on how much Trulieve chooses to repurchase under the program and market conditions.